Quarterly report pursuant to Section 13 or 15(d)

Acquisition and Discontinued Operations (Narrative) (Details)

v3.7.0.1
Acquisition and Discontinued Operations (Narrative) (Details) - USD ($)
3 Months Ended
Sep. 12, 2016
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Business Acquisition [Line Items]        
Net loss   $ 4,353,776 $ (559,511)  
Impairment loss on Goodwill      
BDI [Member]        
Business Acquisition [Line Items]        
Percentage of outstanding voting stock owned by parent 98.00%      
Percentage of Venaxis common stock issued as equity consideration 14.00%      
Inventories acquired       $ 416,000
Inventories raw materials acquired       188,000
Inventories finished goods acquired   49,000   $ 228,000
Total revenue     55,000  
Net loss     $ 399,000  
Loss per share (Basic and Diluted)     $ 0.09  
Impairment loss on Inventory   408,000    
Impairment loss on Goodwill   430,000    
Impairment loss of Equipment and furnishings   38,000    
Impairment loss of Intangible Assests   1,833,000    
Impairment loss on other items   $ 5,000    
BDI [Member] | Common Stock [Member]        
Business Acquisition [Line Items]        
Equity consideration issued for acquisition, number of shares 627,010      
Value of equity consideration issued for acquisition $ 2,577,000